{"id":"https://openalex.org/W2519979747","doi":"https://doi.org/10.1111/j.1755-3768.2016.0278","title":"Gene transfer of prolyl hydroxylase domain 2 inhibits hypoxia\u2010inducible angiogenesis in a model of choroidal neovascularization","display_name":"Gene transfer of prolyl hydroxylase domain 2 inhibits hypoxia\u2010inducible angiogenesis in a model of choroidal neovascularization","publication_year":2016,"publication_date":"2016-09-14","ids":{"openalex":"https://openalex.org/W2519979747","doi":"https://doi.org/10.1111/j.1755-3768.2016.0278","mag":"2519979747"},"language":"en","primary_location":{"id":"doi:10.1111/j.1755-3768.2016.0278","doi":"https://doi.org/10.1111/j.1755-3768.2016.0278","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1755-3768.2016.0278","pdf_url":null,"source":{"id":"https://openalex.org/S21165490","display_name":"Acta Ophthalmologica","issn_l":"0001-639X","issn":["0001-639X","1755-375X","1755-3768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Ophthalmologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057058153","display_name":"Helder Andr\u00e9","orcid":"https://orcid.org/0000-0002-2926-2376","observed_orcids":["https://orcid.org/0000-0002-2926-2376"]},"institutions":[{"id":"https://openalex.org/I4210135386","display_name":"S:t Eriks \u00d6gonsjukhus","ror":"https://ror.org/03z5b5h37","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210135386"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"H. Andre","raw_affiliation_strings":["Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210135386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057274387","display_name":"Parviz Mammadzada","orcid":"https://orcid.org/0000-0003-4171-5291","observed_orcids":["https://orcid.org/0000-0003-4171-5291"]},"institutions":[{"id":"https://openalex.org/I4210135386","display_name":"S:t Eriks \u00d6gonsjukhus","ror":"https://ror.org/03z5b5h37","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210135386"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"P. Mammadzada","raw_affiliation_strings":["Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210135386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079628990","display_name":"Sel\u00e7uk Tunik","orcid":"https://orcid.org/0000-0002-0549-8472","observed_orcids":["https://orcid.org/0000-0002-0549-8472"]},"institutions":[{"id":"https://openalex.org/I4210135386","display_name":"S:t Eriks \u00d6gonsjukhus","ror":"https://ror.org/03z5b5h37","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210135386"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"S. Tunik","raw_affiliation_strings":["Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210135386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026827237","display_name":"Anna Takei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135386","display_name":"S:t Eriks \u00d6gonsjukhus","ror":"https://ror.org/03z5b5h37","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210135386"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"A. Takei","raw_affiliation_strings":["Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210135386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009519666","display_name":"Malena Ekstr\u00f6m","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135386","display_name":"S:t Eriks \u00d6gonsjukhus","ror":"https://ror.org/03z5b5h37","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210135386"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"M. Ekstr\u00f6m","raw_affiliation_strings":["Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210135386"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135386","display_name":"S:t Eriks \u00d6gonsjukhus","ror":"https://ror.org/03z5b5h37","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210135386"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"M. Yu","raw_affiliation_strings":["Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210135386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001949932","display_name":"Monica Aronsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135386","display_name":"S:t Eriks \u00d6gonsjukhus","ror":"https://ror.org/03z5b5h37","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210135386"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"M. Aronsson","raw_affiliation_strings":["Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210135386"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062354919","display_name":"Anders Kvanta","orcid":"https://orcid.org/0000-0003-2194-7490","observed_orcids":["https://orcid.org/0000-0003-2194-7490"]},"institutions":[{"id":"https://openalex.org/I4210135386","display_name":"S:t Eriks \u00d6gonsjukhus","ror":"https://ror.org/03z5b5h37","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210135386"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"A. Kvanta","raw_affiliation_strings":["Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina and Eye Oncology, St Erik Eye Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210135386"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210135386"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":0.8711,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.70895728,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"94","issue":"S256","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.8554999828338623,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.8554999828338623,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.040699999779462814,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10691","display_name":"Retinal Development and Disorders","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prolyl-hydroxylase-domain-2","display_name":"prolyl hydroxylase domain 2","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor","display_name":"hypoxia-inducible factor","score":0.8370000123977661},{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.9240000247955322},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9980000257492065},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7170000076293945},{"id":"https://openalex.org/keywords/retinal-pigment-epithelium","display_name":"retinal pigment epithelium","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hif-1alpha","display_name":"HIF-1\u03b1","score":0.7900000214576721},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8769999742507935},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.6880000233650208},{"id":"https://openalex.org/keywords/hypoxia-pathway","display_name":"hypoxia pathway","score":0.6629999876022339},{"id":"https://openalex.org/keywords/endothelial-cells","display_name":"endothelial cells","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.8053292036056519},{"id":"https://openalex.org/C2781359195","wikidata":"https://www.wikidata.org/wiki/Q5105209","display_name":"Choroidal neovascularization","level":3,"score":0.7100537419319153},{"id":"https://openalex.org/C2778024200","wikidata":"https://www.wikidata.org/wiki/Q2346242","display_name":"Retinal pigment epithelium","level":3,"score":0.6307148933410645},{"id":"https://openalex.org/C2778271429","wikidata":"https://www.wikidata.org/wiki/Q1281049","display_name":"Neovascularization","level":3,"score":0.5698227286338806},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.553225040435791},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.5109125971794128},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.4943227767944336},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.4923781156539917},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4906684160232544},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48454418778419495},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47717514634132385},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.4763646125793457},{"id":"https://openalex.org/C160450060","wikidata":"https://www.wikidata.org/wiki/Q104598479","display_name":"Hypoxia-inducible factors","level":3,"score":0.42670905590057373},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3255199193954468},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.21080708503723145},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12007850408554077},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1146668791770935},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1111/j.1755-3768.2016.0278","doi":"https://doi.org/10.1111/j.1755-3768.2016.0278","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1755-3768.2016.0278","pdf_url":null,"source":{"id":"https://openalex.org/S21165490","display_name":"Acta Ophthalmologica","issn_l":"0001-639X","issn":["0001-639X","1755-375X","1755-3768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Ophthalmologica","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2750846639","https://openalex.org/W1526704950","https://openalex.org/W3032196679","https://openalex.org/W2995507388","https://openalex.org/W2997542977","https://openalex.org/W2885100232","https://openalex.org/W139086082","https://openalex.org/W3099311205","https://openalex.org/W2145543007","https://openalex.org/W4309074940"],"abstract_inverted_index":{"Purpose":[0],"Cellular":[1],"responses":[2],"to":[3,153,254],"hypoxia":[4,71,89,184],"are":[5,16],"mediated":[6],"by":[7,19,25,199],"the":[8,34,47,66,82,88,126,168,173,177,183,244,249],"hypoxia\u2010inducible":[9],"factors":[10],"(HIF).":[11],"In":[12,31,55,110,122],"normoxia,":[13],"HIF\u2010\u03b1":[14],"proteins":[15,86,130],"tightly":[17],"regulated":[18],"a":[20,50,232],"family":[21],"of":[22,41,49,52,68,76,84,125,128,136,172,180,221,228,235,251],"dioxygenases,":[23],"both":[24,213],"proteasomal\u2010mediated":[26],"degradation":[27],"and":[28,38,70,118,138,193,216],"transcriptional":[29],"inactivation.":[30],"hypoxic":[32],"conditions,":[33],"dioxygenases":[35],"become":[36],"inactive":[37],"allow":[39],"formation":[40],"HIF":[42,148,174],"transcription":[43],"factor,":[44],"responsible":[45],"for":[46,243],"upregulation":[48],"myriad":[51],"target":[53],"genes.":[54],"ocular":[56],"neoangiogenic":[57],"diseases,":[58],"such":[59],"as":[60],"neovascular":[61],"age\u2010related":[62],"macular":[63],"degeneration":[64],"(nAMD),":[65],"role":[67],"ischemia":[69],"is":[72,167],"associated":[73,147,187],"with":[74,107,188],"progression":[75],"choroidal":[77,119,139],"neovascularization.":[78],"Here,":[79],"we":[80],"investigate":[81],"effects":[83,127,179],"HIF\u2010regulating":[85,108,129],"on":[87,182],"pathway":[90,185],"in":[91,99,115,133,150,160,196,210,214,217,223,226,231,259],"retinal":[92,117],"pigment":[93],"epithelium":[94],"(RPE)":[95],"cells,":[96,162,212],"critically":[97],"involved":[98],"nAMD":[100,260],"pathogenesis.":[101],"Methods":[102],"ARPE\u201019":[103,161,203],"cells":[104,152,204],"were":[105,186],"transfected":[106],"proteins.":[109],"vitro":[111,215],"angiogenesis":[112,209,230],"was":[113,131],"assayed":[114],"human":[116],"endothelial":[120,211],"cells.":[121,201],"vivo":[123,224],"analysis":[124],"determined":[132],"mouse":[134,233],"models":[135],"iris":[137],"induced":[140],"angiogenesis.":[141],"Results":[142],"Our":[143,156],"previous":[144],"results":[145,239],"have":[146,241],"expression":[149],"RPE":[151],"CNV":[154],"progression.":[155],"data":[157],"indicates":[158],"that,":[159],"prolyl":[163],"hydroxylase":[164],"domain":[165],"(PHD)2":[166],"most":[169],"potent":[170],"negative\u2010regulator":[171],"pathway.":[175],"Furthermore,":[176],"negative":[178],"PHD2":[181,207,222],"decreased":[189],"HIF\u20101a":[190],"protein":[191],"levels,":[192],"concomitant":[194],"decrease":[195],"secreted":[197],"VEGF":[198],"these":[200],"Consequently,":[202],"stably":[205],"expressing":[206],"impaired":[208],"vivo.":[218],"Gene":[219],"transfer":[220],"resulted":[225],"mitigation":[227],"HIF\u2010mediated":[229],"model":[234],"nAMD.":[236],"Conclusions":[237],"These":[238],"may":[240],"implications":[242],"clinical":[245],"treatment,":[246],"particularly":[247],"regarding":[248],"use":[250],"gene":[252],"therapy":[253],"negatively":[255],"regulate":[256],"neoangiogenesis":[257],"present":[258],"patients.":[261]},"counts_by_year":[{"year":2018,"cited_by_count":3}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-09-23T00:00:00"}